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0022-2836/$ - see front matter © 2007 EThis article reports on experimental evidence that an Escherichia coli nanR
mutant shows inhibited growth in N-acetylneuraminic acid. This effect is
prevented when inocula are grown in an excess of glucose, but not in an
excess of glycerol. The nanATEK operon is controlled by catabolite
repression, suggesting that diminished expression of the nanATEK operon
in the presence of glucose explains the inocula effects. Neither double nanR–
nagC nor nanR dam mutants show growth inhibition in the presence of
N-acetylneuraminic acid. A theoretical model of N-acetylneuraminic acid
metabolism (i.e., in particular of the nanATEK and nagBACD operons) is
presented; the model suggests an interpretation of this effect as being due to
transient high accumulations of GlcNAc-6P in the cell. This accumulation
would lead to suppression of central metabolic functions of the cell, thus
causing inhibited growth. Based on the theoretical model and experimental
data, it is hypothesised that the nanATEK operon is induced in a two-step
mechanism. The first step is likely to be repressor displacement by N-
acetylneuraminic acid. The second stage is hypothesised to involve Dam
methylation to achieve full induction.© 2007 Elsevier Ltd. All rights reserved.Edited by J. Kam Keywords: Escherichia coli; N-Acetylneuraminic acid; GlcNAc-6P toxicityIntroduction
Sialic acids comprise a family of nine-carbon keto
amino sugars of which N-acetylneuraminic acid is
the best studied. Largely restricted to animals and
their pathogens, sialic acids commonly occupy the
terminal position in glycoconjugates on eukaryotic
cell surfaces. They are an important nutrient for
many bacteria that colonize animal hosts, even
though some, such as Escherichia coli, lack a sialidase
and hence cannot liberate free N-acetylneuraminic
acid from host glycoconjugates directly. In addition,
microbial pathogens frequently decorate their sur-
faces with sialic acid as a means of circumventing
host defenses; in E. coli, N-acetylneuraminic acid
controls the expression of type 1 fimbrial adhesin
and hence is a regulatory signal (for a recent review,
see Severi et al.1).
Uptake of N-acetylneuraminic acid into the
periplasm of E. coli occurs either via the generaless:
se-6P; WT, wild type.
lsevier Ltd. All rights reserveporins OmpF and OmpC, or via a selective channel
(NanC).2 NanT is required for the transport of
N-acetylneuraminic acid across the cytoplasmic
membrane, and metabolism of N-acetylneuraminic
acid to GlcNAc-6P requires nanATEK.3–6 Expression
of the nanATEK operon is subject to catabolite
repression, and hence is inhibited by glucose and
is activated by Crp.7 Furthermore, it is induced by
N-acetylneuraminic acid, which inactivates the
NanR repressor.7 Two further steps, catalysis by
NagAB and repression by the GlcNAc-6P-respon-
sive regulator NagC, generate the central metabolic
intermediate fructose-6P (Fru-6P) from GlcNAc-6P8
(see Fig. 1).
The operator site for NanR at the nanATEK
promoter forms part of a conserved 27-bp sequence
that is also found upstream of the nanC gene.9 The
conserved element includes a Dam methylation site
(GATCNanR), and NanR binding to its operator
prevents methylation of GATCNanR in vivo at both
nanC10 and nanA (unpublished data). Expression of
both the nanATEK and the nanC operons is de-
creased in a dam mutant.11 Furthermore, GATCNanR
is found within a nucleotide sequence that is
expected to be a relatively poor substrate for Damd.
Fig. 1. Schematic representation of N-acetylneuraminic acid transport and metabolism; details of the pathway are
described in the main text. The bacterial outer membrane (OM) and inner membrane (IM) are represented by vertical
lines. Proteins are boxed, whereas N-acetylneuraminic acid (Neu5Ac) and metabolic intermediates are not. Straight
arrows indicate the flow of metabolic intermediates. The conversion of NanR and NagC from active repressors (NanRA
and NagCA) to inactivated forms (NanRI and NagCI) by Neu5Ac and GlcNAc-6P, respectively, is indicated by bent
arrows. GlcN-1P enters glycolysis by conversion to Fru-6P.
876 Transient Sialic Acid Toxicity of a nanR Mutantmethylase.12 Thus, if methylation of GATCNanR con-
trols the nanATEK and nanC promoters, full expres-
sion of these operons should be delayed until
GATCNanR is methylated following dissociation of
NanR from its operator sites when N-acetylneur-
aminic acid is first encountered.
In this contribution, we will provide experimental
evidence that a mutation of nanR, depending on
the inoculum, may lead to strong growth inhibition
in the presence of N-acetylneuraminic acid. Simul-
taneous mutations of nagC or dam suppress this
effect and lead to growth rates that are more com-
parable to those of the wild type (WT). We inter-
pret the inhibited growth of the nanR mutant in
a N-acetylneuraminic acid assay as a result of
GlcNAc-6P accumulation in the cell; this condition
has previously been shown to have toxic effects,
although the mechanism of toxicity is unknown. 13
We use a differential equation model of the
control mechanisms of the nanATEK and nagBACD
operons and a set of simulations in order to quali-
tatively explain the experimentally observed beha-
viour of the system. The model suggests that the
toxicity is a transient effect (i.e., does not affect the
long-term behaviour of the system). Furthermore, in
conjunction with available experimental data, the
model implies that full induction of nanATEK is
achieved by a two-step mechanism that we propose
could involve methylation of the operator site: In
the first step, the turnover of N-acetylneuraminic
acid in the cell is slowly increased during short
periods of NanR displacement. The second phase
is reached when methylation of the operator site
allows full induction of the nanATEK operon. In
this contribution, we suggest that this two-step
induction mechanism is necessary in order for the
cell to avoid high transient GlcNAc-6P accumula-
tions (with toxic effect), while at the same time
being able to benefit from high steady-state turn-
over rates.Results
N-acetylneuraminic acid delays growth in a
nanR mutant background
Expression of the nanATEK operon is suppressed
by NanR, a FadR-like transcriptional regulator that
is inactivated by N-acetylneuraminic acid. In the
course of growth experiments, we found that rapid
exponential growth in a nanR mutant was delayed
considerably following inoculation into Mops [3-(N-
morpholino) propanesulphonic acid] medium con-
taining N-acetylneuraminic acid as the sole carbon
source (Fig. 2a) and, even after 7 h, was not as rapid
as the WT.
In the experiments described above, inocula were
grown to saturation overnight in a glucose minimal
medium containing a limiting (1.11 mM) amount of
the carbon source.We reasoned that the toxic effect of
N-acetylneuraminic acid was due to overexpression
of the nanATEK operon in the mutant background,
leading to an accumulation of excessive levels of N-
acetylneuraminic acid, or one or more of its metabolic
products. The nanATEK operon is suppressed by
glucose (catabolite expression) independently of
NanR.7 In support of the hypothesis that overexpres-
sion of the nanA operonproducesN-acetylneuraminic
acid toxicity, N-acetylneuraminic acid toxicity was
suppressed completely when the inoculum was
grown overnight in a medium containing an excess
of glucose (22.2 mM) (Fig. 2b). This effect was not
observed when glucose was replaced by glycerol, a
non-catabolite-repressing substrate (data not shown).
It has been shown previously that the accumula-
tion of N-acetylneuraminic acid in a nanA mutant
is growth inhibitory.14 However, it seemed improb-
able to us that an accumulation of N-acetylneurami-
nic acid could explain N-acetylneuraminic acid
toxicity in the nanR mutant, since any excess
Fig. 2. Growth inhibition of a nanRmutant in Mops minimal medium containing N-acetylneuraminic acid. The WTor
mutant strain indicated was inoculated following overnight growth in Mops minimal medium containing (a) 1.11 mM or
(b) 22.2 mM glucose as the sole carbon source. The cultures were incubated at 37 °Cwith rapid aeration. The growth of the
WT and the mutant strains indicated was monitored spectrophotometrically at 600 nM.
877Transient Sialic Acid Toxicity of a nanR MutantN-acetylneuraminic acid taken up by NanT in the
nanRmutant should be converted rapidly toGlcNAc-
6P by the concerted actions of the NanA, NanE, and
NanK. On the other hand, GlcNAc-6P is also known
to be toxic,13 and we reasoned that low initial
induction of the nagBACD operon, and hence an
accumulation of GlcNAc-6P, would more likely be
responsible for N-acetylneuraminic acid toxicity. In
support of this hypothesis, a secondary mutation in
the nagBACD operon repressor nagC suppressed
completely the toxic effects of N-acetylneuraminic
acid in the nanR mutant (Fig. 2b). The mechanism
of GlcNAc-6P toxicity is unknown, but is thought
to involve a lack of intermediary metabolites.13
Consistent with this hypothesis, no growth defect
was observed in a nanRmutant grown in aMops-rich
defined medium that contains exogenous bases and
amino acids (data not shown).
Expression of nanA is activated by Dam meth-
ylation.15 To probe further the potential role of Dam
methylation in the regulation of the nanA operon,
the ability of a dammutation to suppress the effect ofN-acetylneuraminic acid on the nanR mutant was
also examined (Fig. 3). It was found that the dam
mutant restored the growth rate of the nanR mutant
to near-WT levels. This result supports the hypoth-
esis that overexpression of the nanA operon pro-
duces N-acetylneuraminic acid toxicity. Further-
more, it indicates that if methylation of GATCNanR
activates the expression of the nanA operon, then
this effect occurs even in the absence of NanR.
Theory
Formulation of the Base, Extended, and Full
Models will introduce three variants of a model of
N-acetylneuraminic acid metabolism in E. coli. The
first (“base”) model makes a number of simplifying
assumptions, but provides some intuition about the
behaviour of the system. The second (“extended”)
model extends the base model by taking into
account the transcription/translation step in gene
expression. Finally, the third (“full”) model refines
the extended model by introducing more realisticFig. 3. Suppression of N-acetyl-
neuraminic acid toxicity in a nanR
mutant by simultaneous mutation
of dam. The WT or the mutant
strains indicated were inoculated
into fresh Mops minimal medium
containing N-acetylneuraminic acid
as the sole carbon source following
overnight growth in Mops minimal
medium containing 1.11 mM glu-
cose as the sole carbon source. The
cultures where incubated at 37 °C
with rapid aeration. The growth of
the WT and the mutant strains
indicated was monitored spectro-
photometrically at 600 nM.
Table 2. Summary of the main symbols used
s1 N-acetylneuraminic acid (external)
e1 Products of nanATEK
s2 GlcNAc-6P
878 Transient Sialic Acid Toxicity of a nanR Mutantkinetics. This latter model is more complex than the
base and extended models, but shows the same
qualitative behaviour (at least for the purpose of the
current contribution).nR NanR (kept fixed)
x1 N-acetylneuraminic acid in the cytoplasm
e2 Products of nagBACD
ϱex mRNA for enzyme ex
gx Transcription efficiency of
nanATEK and nagBACDFormulation of the base, extended, and full models
Our base model is defined by the following set of
differential equations (Tables 1 and 2):
ds1 ¼ 0 (1)
dx1 ¼ rs1  rs2 (2)
de1 ¼ re1  ce1e1 (3)
ds2 ¼ rs2  rx2 (4)
de2 ¼ re2  ce2e2 (5)
where the parameters of the system are defined in
Table 3. This model describes the flow of external
(periplasmic) N-acetylneuraminic acid (s1) into the
cytoplasm (Eqs. (1) and (2)) via NanT (here rep-
resented by e1). Cytoplasmic N-acetylneuraminic
acid is denoted by x1; its breakdown into GlcNAc-6P
(represented by s2) is catalysed by e1. Differing con-
centrations of NanA/NanB and NanT are taken care
of by the relevant constants describing uptake and
metabolic efficiencies. Regulation of the uptake and
metabolism of N-acetylneuraminic acid is repre-
sented in the model by the transcription efficiency
g (see Table 3) describing the activity of nanATEK.
If g=0, then no e1 is produced, and hence no
N-acetylneuraminic acid is taken up or metabolized,
whereas g=1 describes the case of full nanATEK
derepression and e1 is produced at its maximum
rate (defined by the value of Ve1). Generally, a higher
nR (representing the amount of NanR) leads to a
lower g, and a higher x1 leads to a higher g.
Equations (4) and (5) are the GlcNAc-6P counter-
parts of Eqs. (2) and (3). The symbol e2 represents the
products of the nagBACD operon. The autorepres-
sive activity of NagC is reflected in the transcription
efficiency g2 (see Table 3). Like its counterpart g, g2
varies between 0 and 1. The higher is e2, the lower is
g2. Yet, the higher is g2, the higher are the expression
levels of e2. Similarly, the more s2 (GlcNAc-6P) there
is in the system, the higher is g2. The details of the
GlcNAc-6P breakdown (and its products) are not
represented in this model.
This model contains a number of simplifying
assumptions. In particular, the influx of N-acetyl-Table 1. Summary of the main symbols used
s1 N-acetylneuraminic acid (external)
e1 Products of nanATEK
s2 GlcNAc-6P
nR NanR (kept fixed)
x1 N-acetylneuraminic acid in the cytoplasm
e2 Products of nagBACD
ϱex mRNA for enzyme ex
gx Transcription efficiency of
nanATEK and nagBACDneuraminic acid into the periplasm is not explicitly
modelled because N-acetylneuraminic acid diffuses
through the outer cell wall through the nonspecific
OmpF/OmpC porin;2 uptake into the periplasm is
therefore only weakly regulated. Other simplifying
assumptions include the following:
• Themodel reduces themetabolism ofN-acetylneur-
aminic acid (see Fig. 1) to a two-step process.
• Themetabolic enzymes encoded by nanATEK and
nagBACD are summarised by e1 and e2, respec-
tively. Essentially, this amounts to assuming that
the concentrations of the proteins expressed from
the same operon are in a fixed ratio.
These simplifications can be justified by consider-
ing that (i) they facilitate the mathematical inter-
pretation and treatment of the model. Furthermore,
(ii) this article only considers qualitative models;
simplifications resulting in quantitative inaccuracies
are inconsequential. Finally, (iii) more complex
models would also introduce a number of additional
unknown parameters; these would need to be
guessed and, by themselves, introduce additional
uncertainties.
The base model (i.e., Eqs. (1)–(5)) does not rep-
resent mRNA expression. An extended model that
represents the mRNA expression is identical with
the base model, except for the following replace-
ment of and addition to Eqs. (1)–(5) (Tables 4–7):
d|e1 ¼ d|e1ðre1  |e1Þ (6)
de1 ¼ |e1  ce1e1 (7)
d|e2 ¼ d|e2ðre2  |e2Þ (8)
de2 ¼ |e2  ce2e2 (9)
Note that the steady-state solutions of the extended
model are identical with those of the base model.
From a dynamical point of view, the main difference
between the models is that production of mRNA—
here denoted as ϱex (where x=1, 2)—introduces a
delay into the system. The size of the delay will




The extended model assumes that (i) mRNA
breakdown is negligible, and (ii) proteins are de-
graded at a fixed rate. These assumptions are not
necessarily correct (e.g., see Narang16 and Narang
Table 3. Definition of the dynamical parameters used in
the model of N-acetylneuraminic acid metabolism
gW k2 þ k3x1
k2 þ k3x1 þ k1nR g2W
l2 þ l3s2












The parameter k1 describes the affinity of nR for the operator site,
k2 is the dissociation constant, and k3 is a constant describing the
efficiency of nR displacement by x1. The parameters lx have an
analogous interpretation for e2 and s2. Vs1, Vs2, and Vsc are the
enzymatic rates for N-acetylneuraminic acid transport into the
cytoplasm (i.e., the s1→x1 conversion), the rate of N-acetylneur-
aminic acid breakdown, and the rate of GlcNAc-6P breakdown,
respectively. The parameters Kx are saturation parameters. The
transcription efficiencies g,g2 are derived under the assumption
that displacement of the repressor is a one-step process (i.e., no
intermediate repressor–derepressor–nucleotide compounds are
formed; see Appendix A for the derivation). All parameters are
constant and positive; in this contribution, we restricted the value
of the parameters to the interval (0, 1) (see Materials and Methods
for an explanation).
879Transient Sialic Acid Toxicity of a nanR Mutantand Pilyugin17). A more realistic model would take
into account the limited lifetime of mRNA and
replace fixed-rate protein breakdown with a model
where protein is diluted by cell growth (i.e.,
proportional to the efflux of GlcNAc-6P given by
rx2). The resulting model (which we will henceforth
refer to as the full model) is then obtained by
replacing Eqs. (6)–(9) with the following:
d|e1 ¼ d|e1ðre1  |e1Þ  c||e1 (60)
de1 ¼ |e1  rx2ce1e1 (70)
d|e2 ¼ d|e2ðre2  |e2Þ  c||e2 (80)
de2 ¼ |e2  rx2ce2e2 (90)
The breakdown of mRNA with constant cϱ is
represented by the last terms in Eqs. (6′) and (7′).Derivation of steady-state values
In what follows, we will calculate the steady state
of the base model (which is identical with the steady
state of the extended model).
From Eq. (3), we can calculate steady-state values
for e1:
gVe1  ce1e1 ¼ Ve1
︸Wβ
k2 þ k3x1
k2 þ k3x1 þ k1nR ce1e1 ¼ 0
YhVe1  ce1he1  ce1k1nRe1 ¼ 0
Ye1 ¼ hVe1hce1 þ ce1k1nR
(10)Similarly, using Eq. (2), we can calculate the steady-
state concentration of x1:







AVs2e1 x1Kx1 þ x1
(11)
Yx1 ¼ Vs1jKx1Vs2  Vs1j
(12)
Due to the assumption that the metabolic proteins
NanA and NanB and the transporter NanT are in
a fixed ratio, in this model, the concentration of
N-acetylneuraminic acid (x1) in the cytoplasm is
independent of the induction level of the nanATEK
operon (i.e., e1); this is clear from Eq. (12). The
amount of e1 regulates the turnover rate of N-acet-
ylneuraminic acid (i.e., how fast it is taken up and
converted into GlcNAc-6P). Hence, the level of x1 is
only determined by the parameters of the system
and by the amount ofN-acetylneuraminic acid in the
periplasm.
Using Eq. (4), we obtain a steady-state value for




rs2  rx2 ¼ 0 ¼ Vs2e1a Vce2 s2Kc þ s2YVs2e1aKc þ Vs2e1as2  Vce2s2 ¼ 0
Ys2 ¼ Vs2e1aKcVce2  Vs2e1a
(13)
Here, s2 is a function of the inducers e1, e2, and
x1. Keeping everything else fixed, an increase in e1
(nanATEK induction) will lead to an increase in
s2 (GlcNAc-6P concentration); increasing e1, how-
ever, can only continue as long as the denominator
in Eq. (13) remains greater than zero. An increase
beyond this point will lead to an undefined steady
state (i.e., an unstable model). Apart from e1, the
steady-state concentration of GlcNAc-6P also de-
pends on the external/periplasmic, but not the cyto-
plasmic, N-acetylneuraminic acid concentration.Necessary conditions for the stability of WT
For reasons of biological plausibility, we assume
that the WT will normally operate in a stable dyna-
mical regime (see Computational Simulations for a
discussion of what we mean by stability). The above
steady-state analysis allows one to establish some
necessary conditions for the existence of stable
solutions:
• From Eq. (12): Vs2NσVs1. This essentially means
that the speed with which N-acetylneuraminic
acid is converted must be higher than the speed
with which it is brought into the system.
880 Transient Sialic Acid Toxicity of a nanR Mutant• From Eq. (13): Vce2NVs2e1α. This means that the
influx of GlcNAc-6P must be lower than its efflux
(i.e., metabolic breakdown).
Independent of the parameters, the model has, at
most, one steady-state solution (see Appendix A).
Results for the nanR single mutant
The nanR mutant corresponds to the limiting case
of nR≪k2+k3x1. In this case, e1 will approach the
steady-state value:
enR1 ¼ Ve1=ce1 (14)
Clearly, e1
nRN e1 for any positive nR, confirming the
intuitive expectation that the turnover of N-acet-
ylneuraminic acid is strictly higher in the nanR
mutant than in the WT. As a consequence of the
higher levels of e1 in the mutant, it can be seen from
Eq. (13) that the steady-state values of s2 will be
higher than in the WT. Note, however, that this
model predicts that the N-acetylneuraminic acid
concentration in the cytoplasm will not be affected
by the mutation.
Double mutant
The nanR–nagC double mutant can be calculated
exactly. It is defined by g2=1 and nR=0. In this case,
all variables take very simple solutions in terms of
their parameters. The concentrations of e1 and e2 can
be obtained from Eqs. (3) and (5), respectively:
e1 ¼ Ve1ce1
, e2 ¼ Ve2ce2
(15)










 Vs2 Ve1ce1 a
(16)
Note that, in the limit of very large s2, the single
mutant will show the exact same behaviour as the
double mutant because g2→1 for large s2.
Simulations
Approach of steady state in the extended model
As long as one is only interested in the steady-
state values, the basic model of Eqs. (1)–(5) and the
extended model of Eqs. (1)–(9) are identical. These
models differ, however, in how they approach the
steady state. The transcription step introduces an
additional delay into the system that potentially
modifies the transient behaviour of the model.
In what follows, we will (unless stated otherwise)
assume initial conditions corresponding to very low
(or vanishing) enzyme (i.e., e1 and e2) and mRNAconcentrations. In the case of the basic model, there
are only small delays in the system (depending
on the specific parameters), and the cytoplasmic
steady-state concentrations of x1 and s2 (N-acetyl-
neuraminic acid and GlcNAc-6P, respectively) are
approached from below (i.e., the steady-state con-
centration is the maximum, or is close to the
maximum, concentration reached). If the delay in
the system is significant, then the transient concen-
trations of s2 and/or x1 will initially overshoot their
steady-state concentrations by possibly quite large
amounts. In the extended model, the parameter




Figures 4 and 5 show how the steady state is
approached depending on the size of the delay in
the extended model. For a value of dex
ϱ=0.1, the
system in Fig. 4 shows no significant overshoot of
the steady-state values. Both the WT and the single
nanRmutant approach their respective steady states
from below. With increased delay (i.e., decreasing
the value of dex
ϱ), the qualitative behaviour changes,
and both the WT and the mutant show transient
accumulations of s2 before the steady-state value
is reached. For long delays, these accumulations
can be very significant compared to the steady state.
Accumulations occur in both the WT and the
mutant, but in the particular case of Fig. 4, the
accumulation in the mutant is higher than in the WT
by a factor of 4. Note that, in the extendedmodel, the
steady-state value is independent of the delay dex
ϱ
.
Similarly, for the parameters used in Fig. 5, the
nanR mutant shows a transient accumulation of s2
by a factor of N60 compared to the steady-state value
for a delay of dex
ϱ
= 0.001. Yet again, no accumulation
occurs in the simulation of the nanR–nagC double
mutant.Stability of qualitative behaviour: The full model
While the full model is somewhat more compli-
cated to analyse when compared to the base or
extended model, most of the intuition developed
for the base model can be carried over to the full
model as well. What is more important, however,
is that the full model approaches steady state
qualitatively in the same way as the extended
model does. The model shows an overshoot of s2
that depends on the delay in gene expression.
Figure 6 is an example; here, the overshoot of s2 is
relatively modest, and the difference between WT
and mutant is small. For different parameters, such
as in Fig. 7, the model demonstrates a very large
difference in transient GlcNAc-6P concentrations in
the WT and the mutant.Discussion
N-Acetylneuraminic acid is a carbon source for
E. coli that can be metabolized into GlcNAc-6P and
Fru-6P, eventually fueling the growth of the organism.
However, our results show that too rapid utilization
Fig. 4. Comparison of how GlcNAc-6P approaches steady state for different delays and a different set of parameters.
The double mutant (bottom right) approaches the steady state from below even for significant delays. For the parameters
of this simulation, see Table 4.
881Transient Sialic Acid Toxicity of a nanR Mutantof N-acetylneuraminic acid can lead to growth
inhibition, depending upon the growth conditions
prior to N-acetylneuraminic acid exposure. We will
henceforth assume that this toxic effect is caused by
GlcNAc-6P.
In this section, we will interpret (and connect)
the experimental, theoretical, and simulation
results reported in Results; we will also discuss
how they can be understood in the light of
previous results. The main conclusion is a predic-
tion that nanATEK will be regulated in a two-step
process, in that full induction of the gene is only
reached after an initial period with intermittent
induction. The rationale is that, by using this two-
step process, the cell can efficiently metabolize
N-acetylneuraminic acid and GlcNAc-6P in steady
state while avoiding the toxic effects of transient
(high) accumulations of GlcNAc-6P.
Steady-state behaviour does not explain
GlcNAc-6P toxicity
The lack of growth of the nanR mutant cannot be
explained by the steady-state properties of this (or
indeed any other possible) model. To see this, con-
sider the two possible scenarios that could explain
the observed experimental evidence:
(1) The mutant has a steady-state GlcNAc-6P
concentration that is high enough to causetoxicity, whereas the concentration in theWT is
too low to show any symptoms.
(2) The WT has a nontoxic steady state, but in
the mutant, GlcNAc-6P grows without bounds
(i.e., it does not have a steady state). Translated
into the language of dynamical systems, this
would mean that the WT shows stable beha-
viour, but the mutant is unstable.
A priori, both scenarios are plausible vis-à-vis the
mathematical model: There are sets of parameters
where theWT has a steady state but the mutant does
not; even if the mutant has a steady-state GlcNAc-6P
concentration, for many sets of parameters, it will be
much higher than the WT concentration, thus
potentially causing the toxic effect.
We think that a steady-state explanation is not
correct for the following reasons: Firstly, the para-
meters leading to a stable WT and an unstable mu-
tant are rare in the parameter space of the extended
model (we estimated them to be about 3%; see
Appendix A). However, this estimate is most cer-
tainly dependent on one of our modelling assump-
tions, namely, that nR=0.7 (which we left fixed).
Increasing this value would lead to an increase in
the proportion of models with stable WT but un-
stable mutant. Moreover, one cannot a priori exclude
that evolution chose a rare set of parameters.
A stronger argument is provided by the second
reason: While a small proportion of parameter space
Fig. 5. Comparison of how s2 approaches steady state for different values of the (delay) parameter dex
ϱ. This is an
example simulation. The quantitative details depend on the parameters chosen for the model (listed in Table 5); however,
the qualitative trend of increased transient accumulations for longer delays is independent of the parameters.
882 Transient Sialic Acid Toxicity of a nanR Mutantsupports stable behaviour for the WT and unstable
behaviour for the nanR mutant, we did not find a
single set of parameters where the WT and single
mutant are stable and unstable, respectively, but
the double nanR–nagC mutant is stable. This
suggests that the stable–unstable–stable combina-
tion is at least extremely rare or even nonexistent.
Theoretically, one would indeed not expect to find
a stable–unstable–stable configuration because the
model predicts the nanR mutant and the double
nanR–nagC mutant to be equivalent for large s2
(because g2→1 for s2→∞; i.e., the nagBACD operon
is completely derepressed at high concentrations of
GlcNAc-6P).
Thirdly, experimental evidence directly suggests
non-steady-state explanations. The toxic effect
experienced by the nanR mutant is transient in the
sense that the population recovers and returns to
near-normal growth after a certain period (see Fig. 2)
(i.e., there is no observable toxic effect of GlcNAc-6P
in the long run). Steady-state explanations would
only describe the behaviour of the system in the long
term.
Fourthly, in systems where there is only one stable
steady state, the long-term behaviour of the system
is independent of the initial conditions of
the system. Yet in the experiments, the toxic effect
is only seen in carbon-starved inocula, but not in
inocula grown in carbon-rich conditions. In the
mathematical model, different inoculations manifestthemselves in different initial conditions. If a system
has a steady state that is unique and stable, then its
long-term behaviour does not depend on its initial
conditions. Hence, the fact that the appearance of
toxicity depends on the inoculum indicates that the
effect is not due to the steady-state behaviour of the
system.
In summary, mathematical and experimental
evidence indicates strongly that GlcNAc-6P toxicity
in the nanR mutant is a transient effect. Steady-state
GlcNAc-6P levels are nontoxic in the WT, in the
nanRmutant, and in the double nanR–nagC mutant.
An ansatz based on transient behaviour
Rather than being due to the steady-state proper-
ties of the system, we suggest a model based on
transient accumulations of GlcNAc-6P and subse-
quent toxicity effects. The explanatory ansatz can be
summarised as follows:
• Upon exposure to external N-acetylneuraminic
acid, transient GlcNAc-6P concentrations transi-
ently rise to high levels both in the WT and in the
nanR. These transient accumulations tend to
increase when a delay in the nagBACD gene
expression is introduced.
• The mathematical models can explain the experi-
mentally observed transient toxicity of the nanR
mutant (and its absence in the WT) when
Fig. 6. Comparison of how s2 approaches steady state for different values of the (delay) parameter dex
ϱ for the full
model. Here, nanR repression is efficient; hence, there is a smaller transient effect (see parameters in Table 6).
883Transient Sialic Acid Toxicity of a nanR Mutanttransient NanATEK levels are low in the WT but
high in the mutant.
• A large difference in transient NanATEK concen-
trations between the nanRmutant and theWTcan
be explained when nanATEK derepression by N-
acetylneuraminic acid is inefficient.
• This suggests a two-step model of nan induction,
whereby full induction levels of the operon are
only reached after a period of gradual buildup of
enzyme levels in the cell. This two-step mechan-
ism can avoid toxicity in the WT while still
allowing full utilization of the carbon source.
• This explains available experimental evidence
(i.e., the experiments with the dam mutant in Fig.
3 and data from the literature, especially Kalivoda
et al.7).
In the remainder of this section, we will justify this
model in detail.
Delays cause transient accumulations, but not
in the double mutant
The two most relevant qualitative features of both
the extended and the full models are as follows: (i)
The transient GlcNAc-6P accumulations in the
extended/full model last longer and are greater
the longer the delays (see Figs. 4–7). (ii) Independent
of the delay, the nanR–nagC mutant approaches
the steady-state GlcNAc-6P concentration frombelow (i.e., shows no transient accumulations of s2;
GlcNAc-6P).
An interpretation of experimental data based on
the assumption that GlcNAc-6P toxicity is a tran-
sient phenomenon immediately explains aspects of
the available data: The toxicity effect in the nanR
mutant, one can hypothesize, is caused by transient
accumulations of GlcNAc-6P, which in turn are
caused by a (normal) delay in induction of the
system. Once the toxic limit is reached, this normal
delay is exacerbated by even higher GlcNAc-6P
accumulations until eventually the cell manages to
return to normal function. In the double mutant,
the nagBACD operon will always be fully expressed
(due to the absence of the repressing NagC), hence
steady-state concentrations of the relevant enzymes
will be reached; breakdown of the GlcNAc-6P
commences without delay upon the cell's exposure
to N-acetylneuraminic acid.
This ansatz has a potential problem apparent from
Figs. 4 and 6: Unlike the solutions in Figs. 5 and 7,
GlcNAc-6P accumulates in these simulations to
similar levels in both the WT and the nanR mutant.
This suggests that there are regions in parameter
space where both the WT and the nanRmutant tran-
siently accumulate toxic concentrations of GlcNAc-
6P. This leaves a crucial aspect of the model under-
explained, namely, the experimentally observed
difference in qualitative behaviour between the WT
and the single mutant.
Fig. 7. Comparison of how s2 approaches steady state for different values of the (delay) parameter dex
ϱ for the full
model. Here, nanR repression is inefficient (see parameters in Table 7); hence, there is a large transient effect. The last panel
shows s2 on a log scale because of the great differences between the three curves.
884 Transient Sialic Acid Toxicity of a nanR MutantOne possible explanatory strategy is to simply
acknowledge that the parameters of the real systems
happen to be such that the WT does not display a
high transient GlcNAc-6P accumulation while the
nanRmutant does (clearly, there are parameters that
support this). The force of this argument is, in fact,
much stronger than it seems at a first glance: The
absence of toxic GlcNAc-6P accumulations in the
WT per se does not require any explanation because
toxicity impairs viability. What remains to be
explored, at this point, is under which conditions
the system would accumulate high transient
GlcNAc-6P concentrations in the mutant, while the
WT only shows small accumulations.
In Figs. 4 and 5 (for the extended model) and in
Figs. 6 and 7 (full model), the GlcNAc-6P accumula-
tion in the mutant is always higher than in the WT.
Theoretically, this is expected to be the case for all
possible parameter sets because the nanR mutant
has a higher influx of GlcNAc-6P than the WT, while
the regulation of the GlcNAc-6P metabolism is
assumed to be the same as in the WT. Yet, the
difference between the accumulation in the WT and
the accumulation in the mutant will crucially
depend on the parameters of the system; it could
range from very small to very large (as illustrated
by the examples in Figs. 4–7). This leads to two
questions: (i) Theoretically, which parameters deter-
mine the difference in transient behaviour? (ii) Arethere any plausible biological reasons to expect a
big/small difference in transient GlcNAc-6P
between the WT and the mutant in the cell?
Addressing (ii) first, biologically, it is plausible
to expect that the maximum GlcNAc-6P concen-
tration in the WT will be well below toxic levels.
If steady-state GlcNAc-6P values in the WT were
close to the toxic limit, random fluctuations
would take the cell over this limit. Combined
with the experimental evidence on growth inhibi-
tion in the mutant, this suggests that the dif-
ference between maximum transient GlcNAc-6P
accumulation in the WT and maximum transient
GlcNAc-6P accumulation in the nanR mutant
should be large.
What determines transient GlcNAc-6P
accumulations?
In order to get a better theoretical understanding
of the conditions that lead to a large difference in
transient GlcNAc-6P levels, consider that the max-
imum transient GlcNAc-6P accumulation will
depend on the rate of GlcNAc-6P synthesis (i.e.,
GlcNAc-6P influx) and its breakdown rate (i.e.,
efflux). Assuming (for the moment) a fixed efflux
mechanism, then accumulation levels will mainly
depend on the N-acetylneuraminic acid turnover
rate. This rate itself depends on the induction levels
Fig. 8. The transient values of
GlcNAc-6P depend on the concen-
tration of the enzyme regulating
N-acetylneuraminic acid through-
put. In these simulations, x1 was
kept constant at 1, and e1 was set to
various levels ranging from 0.3 to
1.5. Enzyme levels will be high in
the nanR mutant compared to the
WT if NanR is an effective repressor
over physiological levels of N-acet-
ylneuraminic acid (see the main text
for details).
885Transient Sialic Acid Toxicity of a nanR Mutantof nanATEK (e1 in the model). Figure 8 shows s2 (i.e.,
GlcNAc-6P) accumulations for various levels of e1;
in this graph, the parameters regulating the break-
down of s2 have been kept constant. The figure
clearly illustrates that (at least for this particular set
of parameters) increasing the amount of e1 leads to a
higher transient GlcNAc-6P accumulation. Fig. 8
only describes the behaviour of a specific set of
parameters for GlcNAc-6P breakdown. However,
any set of parameters will show a qualitatively
similar trend, with only the quantitative details (i.e.,
the absolute values of s2 accumulation) being dif-
ferent. In terms of the regulation of the GlcNAc-6P
metabolism, a high difference in e1 in the model
translates into a high difference in nanATEK repres-
sion in the cell between the WT and the nanR
mutant. Since the nanR mutant is fully derepressed,
this means that the WT is, at most, partially induced
even in the presence of external N-acetylneuraminic
acid. In short, the difference in transient GlcNAc-6P
levels between the WT and the mutant will be big if
N-acetylneuraminic acid does not efficiently dere-
press nanATEK.
In the full model, the same qualitative relation
between the overshoot in the WT and the mutant
holds true. Figures 6 and 7 are two examples of
the possible behaviour of the full model under
different delays. The qualitative difference
between the two figures is reflected in the
parameters and in the gene transcription efficiency
g. Its value (for the WT) in the simulation in Fig. 6
is around 0.9, indicating nearly full induction of
the genes; the corresponding value in Fig. 7, on
the other hand, never rises above 0.24, indicating
poor derepression for this set of parameters (data
not shown).
A delay explains the experimental data if NanR
displacement is inefficient
In terms of the understanding of the qualitative
properties of the N-acetylneuraminic acid meta-
bolic network, this points to a scenario wherebynanATEK is strongly repressed by NanR even in
the presence of N-acetylneuraminic acid. This is so
for the following reason: If steady-state amounts of
N-acetylneuraminic acid could efficiently derepress
nanATEK, then one would expect only small dif-
ferences in the transient phases of the WT and the
mutant because, even in the former, nanATEK
would be derepressed; the situation is then more
like the example simulations shown in Fig. 4
or Fig. 6, rather than the ones shown in Fig. 5 or
Fig. 7.
This interpretation is consistent with experimental
evidence reported by Kalivoda et al., who used in
vitro gel mobility experiments to demonstrate that
NanR displacement by N-acetylneuraminic acid is
inefficient.7 However, in the same article, the
authors also reported very high in vivo induction
levels of nanATEK in the presence of sialic acid.
Hence, overall, the evidence was somewhat contra-
dictory. Kalivoda et al. speculated (and provided
some experimental evidence) that the difference
between the in vivo and the in vitro results might be
due to the specificity of N-acetylneuraminic acid
uptake for a specific isomer of N-acetylneuraminic
acid (the α-isomer).
While the isomer specificity of NanT could
provide a partial resolution of this contradiction,
our mathematical model indicates that inefficient
nanATEK induction by N-acetylneuraminic acid
could be an adaptive feature with biological reality
in vivo: At the level of the individual cell, inefficient
NanR displacement means intermittent periods
of nanATEK activation; the resulting short pulses
would gradually build up enzyme levels (and
N-acetylneuraminic acid turnover rates) and, as
such, significantly reduce the risk for GlcNAc-6P
accumulations.
This ansatz explains why the WT can avoid the
toxic effect; however, it would also imply a lower
steady-state N-acetylneuraminic acid turnover rate
for the WT, and hence suboptimal nutrient utiliza-
tion (suboptimal because, as the nanR mutant
indicates, the fully derepressed phenotype is, in
886 Transient Sialic Acid Toxicity of a nanR Mutantsteady state, fully viable while providing a higher
nutrient uptake rate). This is not compatible with
available experimental evidence showing similar
growth rates for nanR mutants (taken from the
inocula that are not toxic) and the WT. A possible
way to circumvent this problem is a two-step
inductionmodel, whereby the initial phase of pulsed
nanATEK activity is followed by full induction of the
operon; this would require a second mechanism to
effect the full induction. Such a two-step model of
nanATEK induction could combine avoidance of
toxic transient GlcNAc-6P accumulations with high
steady-state N-acetylneuraminic acid turnover.
We propose that methylation of the NanR-binding
site at the nanA promoter could participate in the
two-step induction of the nanATEK operon. There
are several possible scenarios as to how methylation
could work. One possibility is that the methylated
operator activates nanATEK independently of NanR
binding; another is that the affinity of NanR for the
methylated operator is sufficiently lowered to
enable more efficient displacement by N-acetylneur-
aminic acid. Both possibilities require that (i) NanR
bound to the operator acts as a methylation-
blocking factor, which we know it does, and (ii)
methylation of the free operator is (relatively)
inefficient. As the nucleotide sequence surrounding
GATCNanR (CCAGATCAAT) is expected to make
the GATC site a relatively poor substrate for Dam
methylase,12 this second requirement also seems
likely to be fulfilled.
Since we have shown that mutation of dam can
suppress N-acetylneuraminic acid toxicity, our
experimental evidence suggests that methylation of
GATCNanR per se, rather than an effect of GATCNanR
methylation on NanR binding, is likely to partici-
pate in the control of the nanA operon. However,
further work is needed to determine if and how
methylation of GATCNanR affects the expression
of the nanATEK operon directly and to rule out
the possibility that methylation does affect the
affinity of NanR for its operator in the presence of
N-acetylneuraminic acid.
Theoretically, the two-step model could work as
follows: Assuming that the concentrations of N-acet-
ylneuraminic acid and NanR are constant, and that
the association and displacement rates for NanR
are λ and γ, respectively, then the probability of
nanATEK being repressed (at timeTr followingNanR
binding) or induced (at time Ti following NanR
displacement) will be distributed exponentially:
PrðTr ¼ tÞ~exp Etð Þ, PrðTi ¼ tÞ~exp gtð Þ (17)
Formally, the system can be modelled as a two-state
continuous-time Markov chain. Then the probability
of finding the system in either of its state at a given
time tk is determined by the quotient of the transition
rates, that is,
time spent in repressed state
time spent in induced state
¼ g
E
(18)At the level of the individual cell, inefficient dis-
placement of NanR by N-acetylneuraminic acid
means precisely that this quotient γ/λ is very small
(i.e., that nanATEK is repressedmost of the time). This
again means that there will only be short pulses of
nanATEK expression and hence low initial rates
of N-acetylneuraminic acid turnover, preventing
GlcNAc-6P toxicity.
These short pulses of gene activity could not
explain the experimentally observed full nanATEK
induction as reported by Kalivoda et al. Yet,
methylation could come in as a plausible second-
step mechanism to effect full operon induction:
Assuming a constant N-acetylneuraminic acid con-
centration, then the time to methylation Tm will
again be exponentially distributed, but with the
methylation rate of the unprotected GATC site
modified by the probability of NanR not being
bound to the operator:





This suggests the plausibility of a two-step model of
nanATEK induction. During the first phase, the
operon is expressed intermittently in order to slowly
increase N-acetylneuraminic acid turnover and to
avoid toxic GlcNAc-6P levels.Conclusion
The overall picture emerging from this is as fol-
lows: Exposure of the nanR mutant to N-acetylneur-
aminic acid leads to a transient accumulation of
GlcNAc-6P in the cell, with a toxic effect. The exis-
tence of GlcNAc-6P toxicity in E. coli is well
documented in the literature (and corroborative
evidence is reported in this contribution), although
we do not currently have a mechanistic understand-
ing of this effect. Delays in cell functions such as gene
expression are a result of the GlcNAc-6P toxic effect.
These delays lead to even higher transient accumula-
tions of GlcNAc-6P, triggering a positive feedback of
toxicity. Eventually, however, the GlcNAc-6P concen-
tration will fall back to the (nontoxic) steady-state
concentration. At this point, the toxic effect disap-
pears, and cell function returns to normal. The double
nanR–nagC mutant does not show any toxic effect
because even in the absence of external N-acetylneur-
aminic acid, nan is fully expressed, and hence there
exists no delay in gene expression and GlcNAc-6P
levels are approached from below.
The WTwould be susceptible to the same toxicity
effect as the nanR mutant, unless N-acetylneurami-
nic acid turnover in the cell is initially increased
significantly more slowly in theWT than in the nanR
mutant. This could be achieved if, in E. coli, nanR
displacement by N-acetylneuraminic acid was in-
efficient, only allowing intermittent activity of
nanATEK. Such a model is consistent with measure-
ments of the in vitro displacement efficiency of
N-acetylneuraminic acid as reported by Kalivoda
Table 5. The parameters used to simulate the extended








887Transient Sialic Acid Toxicity of a nanR Mutantet al.; however, it does not account for empirical
evidence for full nanATEK induction in vivo (as
suggested by the experiments reported in this
contribution and by Kalivoda et al.).7 In order to
account for this, we predict a second mechanism
that can lead to full induction of the operon after a












Ks0 0.286851Materials and Methods
Bacterial strains, plasmids, media, and growth
conditions
Bacterial strains, which were all derivatives of the E. coli
K-12 strain BGEC905, have been described in detail
previously.18
Minimal Mops medium was prepared as described by
Neidhardt et al. and supplemented with 10 mM thiamine,
1.32 mM phosphate, and glycerol or glucose, and/or
N-acetylneuraminic acid was added to a final concentra-
tion of 1.11 mM.19 All reagents were obtained from Sigma,
except for N-acetylneuraminic acid, which was purchased
from Merck Biosciences.
Cells were grown aerobically at 37 °C in minimal Mops
medium, with the carbon source as indicated and
subcultured to a starting OD600 of 0.01. Culture densities
were then monitored hourly spectrophotometrically at
600 nm.
Computational simulations
The quantitative details of the system modelled by
Eqs. (1)–(9) strongly depend on the particular choice of
the unknown parameters. Determining these parameters
either experimentally or through literature search is
resource demanding, and the results are likely to be subject
to largeuncertainties.Hence, insteadof guessing the “right”
parameters of the system, the properties of the model were
examined for a wide range of possible parameters.
Throughout the text, we refer to “stable” systems or
models; by this, we mean a set of parameters such that, for
all variables of the system, there exists at least one stable
steady state. In particular, a stable system will not showTable 4. The parameters used to simulate the extended


















Ks0 0.713628unbounded growth of the concentrations of one or more
molecular species.
We estimate the proportion of parameters that lead to
stable models by creating a large number of random
models [i.e., instantiations of the above (basic) model
with random parameter values]. We check each of these
models for stability and are thus able to estimate the
proportion of stable models in the space of all models.
For practical reasons, we limit the value of parameters to
values between 0 and 1 (drawn from a uniform
distribution); restricting the range of possible parameters
to this interval does not limit the generality of our
conclusions because we are not interested in the absolute
value of the parameters, but in their relative magnitudes.
All searches of the parameter space reported in this
contribution were unrestricted (i.e., also included those
regions of parameter space that are known to be
unstable). The simulated WT was always assumed to
have an arbitrary but fixed value of nR=0.7.
The simulations of the transient behaviour were
performed using the standard numerical integrator of the
Maple9 software package. The value of s1 was kept
constant at a high (saturation level) of 4000 (arbitrary
units); independent of the specific parameter values, this










































888 Transient Sialic Acid Toxicity of a nanR MutantThe single nanR mutant was simulated by setting the
value of nR to 0. The nagC mutant was simulated by
setting the value of g2 to 1. Furthermore, in the simulations
of the transient behaviour of the nagC mutant, the initial
conditions of ϱe2 were determined as follows:
• Set the value of s1 (external N-acetylneuraminic acid)
to 0.
• Determine the steady-state concentrations e2ss and ϱe2ss
of e2 and ϱe2, respectively, through simulation.
• Simulate the system again using the standard value of
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Wellcome Trust.Appendix A. The Base Model Has, at
Most, One Solution
Solving Eq. (5) gives the following expression for
e2:






where T1=ce2l2+ce2s2l3 and T2=4ce2l1Ve2l2+4ce2l1Ve2s2l3.
It is immediately clear that only the “+” solution
gives physically meaningful (i.e., positive real)
steady-state values for e2. In order for the “+”
solution to be positive, the expression under the
square root needs to be greater than T2. This is
trivially always the case. Hence, e2 has exactly the
same number of steady-state solution as s2.Using computational algebra systems, it is feasible
to generate explicit solutions of s2 in terms of
parameters of the system. These solutions, however,
are extremely complicated and, therefore, not
insightful. In the general case, s2 will have several
solutions. The relevant question in the current
context is how many physically realistic (i.e.,
positive real) solutions s2 has. Addressing this
question does not require a full solution of s2.
From Eq. (13), we can see that s2 only has a steady-
state solution if e2N e1αVs2/Vc; here, e1 and α can be
substituted by combinations of parameters only.
This means that, if the system has at least one steady
state, then e2 must be greater than some positive
constant C0 (without worrying, for the moment,
about its exact value):
e2  C0N0 (A2)
Given the known expression for the steady state of e2
from Eq. (A1) and given that we require e2 to be
positive real, we obtain:
T1 þ ðT21 þ T2Þ1=2NC1 (A3)
Again, here, C1=2ce2l1C0 summarises a combination
of some constant parameters. This equation means
that there exists a positive constant K such that:
T22 2T1C1  C21  K ¼ 0Ys2




This tells us that, depending on the parameters, s2
has either no or a unique steady-state solution; e2
has always the same number of steady-state
solutions as s2.
The conclusion that there exists, at most, one
steady state might have to be modified if one
assumed additional nonlinearities in the model.
These could, for example, arise from cooperativity
between derepressors. We have investigated this
question numerically (data not shown) and found
that, over a wide range of possible cooperativity
assumptions, themodel still has, atmost, one steady-
state solution. Furthermore, whenever we found
more than one steady-state solution, then there was
still only one attractor solution. While our numerical
experiments do certainly not amount to a mathe-
matical proof, there is a general argument to support
the conclusion: Multistability in biochemical net-
works is mostly associated with activators rather
than with repressors.20 Given that the interactions
in this system are mostly repressive, the existence of
multiple stable steady states would be unexpected.
We can therefore exclude the possibility of multiple
stable steady states.
We also solved a number of random instantiations
of the extend model (see Materials andMethods). As
theoretically predicted, we found not a single set of
parameters for which there were multiple steady-
state solutions. Of a sample of size of 81,000, 32.5%
889Transient Sialic Acid Toxicity of a nanR Mutantleads to stable behaviour in the WT with nR=0.7.
Based on a sample of 33,000, an estimated 29.5%
shows stable behaviour for both the WT and the
NanR mutant. Finally, we found not a single ins-
tance where the WT and the double mutant were
stable but the nanR mutant was unstable. Note that
these experiments were performed over the entire
parameter space, ignoring the restriction to the
identified feasible values reported above.
The density of steady-state solutions for the full
model crucially depends on the mRNA breakdown
rate. For high mRNA breakdown rates, steady-state
solutions become very sparse, particularly for longer
delays. This is so because mRNAwill increasingly be
broken down before it could be translated; this, in
turn, could lead to metabolic bottlenecks, where
the efflux rate falls below the influx rate, leading to
the accumulation of metabolites. Our numerical
simulations have shown that, similarly to the
extended model, there exists, at most, one positive
real solution for the full model.Appendix B. Derivation of Transcription
Efficiencies
We assume that NanR is displaced by GlcNAc-6P
in one step; that is, using the variable names from





ð1 gÞ þ x1Y
k3
gþ x1 þ nR (B2)
Here, g is the probability with which the relevant
gene is turned on; this quantity is described by the
following differential equation:
g ¼ gnRk2 þ ð1 gÞk2 þ ð1 gÞx1k3 (B3)
By setting g ̇=0, one obtains an equation that can be
solved for g:
g ¼ k2 þ x1k3
nRk1 þ k2 þ x1k3 (B4)References
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